A phase 1b dose-escalation/expansion study of BET inhibitor RO6870810 in patients with advanced multiple myeloma.

Journal Article (Letter;Multicenter Study)

Full Text

Duke Authors

Cited Authors

  • Ramasamy, K; Nooka, A; Quach, H; Htut, M; Popat, R; Liedtke, M; Tuchman, SA; Laubach, J; Gasparetto, C; Chanan-Khan, A; Hertzberg, M; deMario, M; Nueesch, E; Chesne, E; Franjkovic, I; Lechner, K; Kornacker, M; Cho, HJ

Published Date

  • September 3, 2021

Published In

Volume / Issue

  • 11 / 9

Start / End Page

  • 149 -

PubMed ID

  • 34480019

Pubmed Central ID

  • PMC8417099

Electronic International Standard Serial Number (EISSN)

  • 2044-5385

Digital Object Identifier (DOI)

  • 10.1038/s41408-021-00545-w

Language

  • eng

Conference Location

  • United States